Richard Graham
2023
In 2023, Richard Graham earned a total compensation of $1.4M as Former Senior Vice President, Strategic Advisor R&D at Theravance Biopharma, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $130,000 |
|---|---|
| Salary | $518,333 |
| Stock Awards | $753,000 |
| Other | $5,000 |
| Total | $1,406,333 |
Graham received $753K in stock awards, accounting for 54% of the total pay in 2023.
Graham also received $130K in non-equity incentive plan, $518.3K in salary and $5K in other compensation.
Rankings
In 2023, Richard Graham's compensation ranked 765th out of 2,221 executives tracked by ExecPay. In other words, Graham earned more than 65.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 765 out of 2,221 | 66th |
Division Manufacturing | 440 out of 1,203 | 63rd |
Major group Chemicals And Allied Products | 298 out of 673 | 56th |
Industry group Drugs | 290 out of 644 | 55th |
Industry Pharmaceutical Preparations | 199 out of 464 | 57th |
Source: SEC filing on April 5, 2024.
Graham's colleagues
We found two more compensation records of executives who worked with Richard Graham at Theravance Biopharma in 2023.